Epidemiological and Clinical Characteristics of Patients with Sarcoma in Erbil City
Keywords:
Sarcoma, Clinical Oncology, Ewing Sarcoma, Osteosarcoma, LiposarcomaAbstract
Sarcoma account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while malignant bone tumors make up just over 10% of sarcomas. This study is assigned to highlight the epidemiological and clinical characteristics of patients with sarcoma in Erbil city. A cross sectional study consisted of 151 diagnosed sarcoma patients who visited Rzgary teaching hospital – medical oncology unit from February 2018 to December 2020. Subjects of ? 14-year-old are excluded from the study. The largest proportion of the sample (23.2%) were aged 10-19 years, and 21.9% were aged 20-29 years. More than half (58.3%) were males. Around (58.3%) of the patients had never smoked, and 18.5% were current smokers. Only 2% of patients used to drink alcohol, and 17.9% had family history of cancers. The most common site of sarcoma was limbs (43%), followed trunk (38.4%), and it was mainly (85.4%) a soft tissue tumor. The most common histo-pathological type was Ewing sarcoma of soft tissue (25.8%), followed by osteosarcoma (21.2%) and liposarcoma (18.2%). This study concluded that sarcoma is more common among people in the second decade of life, the limbs were the most common site of involvement and soft tissue sarcoma accounts majority of the cases.
References
. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov).
. Lahat, G., Lazar, A., & Lev, D. (2008). Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surgical Clinics of North America, 88(3), 451-481.
. A Snapshot of Sarcoma. http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots, National Cancer Institute. Sept 2010.
. Howlader, N. N. A. K. M., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., ... & Cronin, K. A. (2014). SEER cancer statistics review, 1975–2012. National Cancer Institute.
. Bauer, H. C., Trovik, C. S., Alvegård, T. A., Berlin, Ö., Erlanson, M., Gustafson, P., ... & Wiklund, T. (2001). Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica, 72(2), 150-159.
. Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Annals of surgery, 260(3), 416.
. ESMO/European Sarcoma Network Working Group. (2014). Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology, 25, iii113-iii123.
. Howlader, N. N. A. K. M., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., ... & Cronin, K. A. (2014). SEER cancer statistics review, 1975–2012. National Cancer Institute.
. Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Annals of surgery, 260(3), 416.
. Howlader, N. N. A. K. M., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., ... & Cronin, K. A. (2014). SEER cancer statistics review, 1975–2012. National Cancer Institute.
. Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Annals of surgery, 260(3), 416.
. ESMO/European Sarcoma Network Working Group. (2014). Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology, 25, iii113-iii123.
. Rouhani, P., Fletcher, C. D., Devesa, S. S., & Toro, J. R. (2008). Cutaneous soft tissue sarcoma incidence patterns in the US: an analysis of 12,114 cases. Cancer: Interdisciplinary International Journal of the American Cancer Society, 113(3), 616-627.
. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008)
. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
. Che-Jui Lee, Agnieszka Wozniak, Thomas Van Cann, Iris Timmermans, Jasmien Wellens, Ulla Vanleeuw, Inge H. Briaire-de Bruijn, Christian Britschgi, Judith V. M. G. Bovée, Inti Zlobec, Raf Sciot, Patrick Schöffski, Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research, Sarcoma, 10.1155/2021/6675260, 2021, (1-12), (2021).
. S. Foersch, M. Eckstein, D.-C. Wagner, F. Gach, A.-C. Woerl, J. Geiger, C. Glasner, S. Schelbert, S. Schulz, S. Porubsky, A. Kreft, A. Hartmann, A. Agaimy, W. Roth, Deep learning for diagnosis and survival prediction in soft tissue sarcoma, Annals of Oncology, 10.1016/j.annonc.2021.06.007, (2021).
. Serena Pillozzi, Andrea Bernini, Ilaria Palchetti, Olivia Crociani, Lorenzo Antonuzzo, Domenico Campanacci, Guido Scoccianti, Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level, Cancers, 10.3390/cancers13123044, 13, 12, (3044), (2021).
. Ilse van Eck, Dide den Hollander, Ingrid M.E. Desar, Vicky L.M.N. Soomers, Michiel A.J. van de Sande, Jacco J. de Haan, Cornelis Verhoef, Ingeborg J.H. Vriens, Johannes J. Bonenkamp, Winette T.A. van der Graaf, Winan J. van Houdt, Olga Husson, Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study, Cancers, 10.3390/cancers12113083, 12, 11, (3083), (2020).
. Gamboa, A. C., Gronchi, A., & Cardona, K. (2020). Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine. CA: a cancer journal for clinicians, 70(3), 200-229.
. Blay, J. Y., Le Cesne, A., & Demetri, G. D. (2020). The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments. Expert review of anticancer therapy, 20(sup1), 29-39.
. Annovazzi, A., Rea, S., Zoccali, C., Sciuto, R., Baldi, J., Anelli, V., ... & Ferraresi, V. (2020). Diagnostic and Clinical Impact of 18F-FDG PET/CT in Staging and Restaging Soft-Tissue Sarcomas of the Extremities and Trunk: Mono-Institutional Retrospective Study of a Sarcoma Referral Center. Journal of Clinical Medicine, 9(8), 2549.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Scientific Research and Researchers Association (ISRRA)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who submit papers with this journal agree to the following terms.
